| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25075351c1dbea503efe80e53c0e11bb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
1991-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b058931141aed8bab2c1157e282ebb2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9b3e51080fa193a22bc4678e05c3ce0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ffa13964325665b40db94e59fe8ebae |
| publicationDate |
1993-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0562041-A1 |
| titleOfInvention |
Subsaturated transdermal drug delivery device exhibiting enhanced drug flux |
| abstract |
Transdermal administration of hydrophobic drugs via a delivery mechanism in which the drug is dissolved in a carrier at concentrations between 10% and 80% of the saturation concentration. The flow of drug from the device is non-Flickian and is significantly greater than the flow observed when the drug is at saturation. |
| priorityDate |
1990-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |